Search

Phuong N. Huynh

Examiner (ID: 3827, Phone: (571)272-0846 , Office: P/1644 )

Most Active Art Unit
1644
Art Unit(s)
1641, 1644
Total Applications
2195
Issued Applications
1131
Pending Applications
251
Abandoned Applications
828

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5241775 [patent_doc_number] => 20070020267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Anti-VEGF antibodies' [patent_app_type] => utility [patent_app_number] => 11/414742 [patent_app_country] => US [patent_app_date] => 2006-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 53921 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020267.pdf [firstpage_image] =>[orig_patent_app_number] => 11414742 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/414742
Anti-VEGF antibodies Apr 26, 2006 Issued
Array ( [id] => 5857955 [patent_doc_number] => 20060228372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Methods for modulating angiogenesis' [patent_app_type] => utility [patent_app_number] => 11/403387 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21249 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20060228372.pdf [firstpage_image] =>[orig_patent_app_number] => 11403387 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/403387
Methods for modulating angiogenesis Apr 12, 2006 Issued
Array ( [id] => 5580910 [patent_doc_number] => 20090176256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Methods and Products for Evaluating an Immune Response to a Therapeutic Protein' [patent_app_type] => utility [patent_app_number] => 11/887782 [patent_app_country] => US [patent_app_date] => 2006-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21571 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176256.pdf [firstpage_image] =>[orig_patent_app_number] => 11887782 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/887782
Methods and products for evaluating an immune response to a therapeutic protein Apr 3, 2006 Issued
Array ( [id] => 5753446 [patent_doc_number] => 20060222595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Nanoparticles for therapeutic and diagnostic applications' [patent_app_type] => utility [patent_app_number] => 11/392448 [patent_app_country] => US [patent_app_date] => 2006-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7217 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20060222595.pdf [firstpage_image] =>[orig_patent_app_number] => 11392448 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/392448
Nanoparticles for therapeutic and diagnostic applications Mar 28, 2006 Abandoned
Array ( [id] => 318349 [patent_doc_number] => 07521056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'Stably tethered structures of defined compositions with multiple functions or binding specificities' [patent_app_type] => utility [patent_app_number] => 11/391584 [patent_app_country] => US [patent_app_date] => 2006-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 45888 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521056.pdf [firstpage_image] =>[orig_patent_app_number] => 11391584 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/391584
Stably tethered structures of defined compositions with multiple functions or binding specificities Mar 27, 2006 Issued
Array ( [id] => 285217 [patent_doc_number] => 07550143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses' [patent_app_type] => utility [patent_app_number] => 11/389358 [patent_app_country] => US [patent_app_date] => 2006-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 22372 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550143.pdf [firstpage_image] =>[orig_patent_app_number] => 11389358 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/389358
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses Mar 23, 2006 Issued
Array ( [id] => 177531 [patent_doc_number] => 07655238 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Compositions and methods for enhancing the immunogenicity of antigens' [patent_app_type] => utility [patent_app_number] => 11/376572 [patent_app_country] => US [patent_app_date] => 2006-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21299 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655238.pdf [firstpage_image] =>[orig_patent_app_number] => 11376572 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/376572
Compositions and methods for enhancing the immunogenicity of antigens Mar 15, 2006 Issued
Array ( [id] => 5785439 [patent_doc_number] => 20060205067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Compositions and methods for enhancing the immunogenicity of antigens' [patent_app_type] => utility [patent_app_number] => 11/376564 [patent_app_country] => US [patent_app_date] => 2006-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21177 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205067.pdf [firstpage_image] =>[orig_patent_app_number] => 11376564 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/376564
Compositions and methods for enhancing the immunogenicity of antigens Mar 15, 2006 Issued
Array ( [id] => 169843 [patent_doc_number] => 07662396 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Compositions and methods for enhancing the immunogenicity of antigens' [patent_app_type] => utility [patent_app_number] => 11/373528 [patent_app_country] => US [patent_app_date] => 2006-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 29 [patent_no_of_words] => 24894 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662396.pdf [firstpage_image] =>[orig_patent_app_number] => 11373528 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/373528
Compositions and methods for enhancing the immunogenicity of antigens Mar 12, 2006 Issued
Array ( [id] => 5677428 [patent_doc_number] => 20060182783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Sustained release intraocular drug delivery systems' [patent_app_type] => utility [patent_app_number] => 11/370301 [patent_app_country] => US [patent_app_date] => 2006-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 26192 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20060182783.pdf [firstpage_image] =>[orig_patent_app_number] => 11370301 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/370301
Sustained release intraocular drug delivery systems Mar 7, 2006 Abandoned
Array ( [id] => 5618968 [patent_doc_number] => 20060188501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Diagnostic and therapeutic agents for rheumatoid arthritis' [patent_app_type] => utility [patent_app_number] => 11/360436 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8068 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188501.pdf [firstpage_image] =>[orig_patent_app_number] => 11360436 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/360436
Diagnostic and therapeutic agents for rheumatoid arthritis Feb 23, 2006 Abandoned
Array ( [id] => 5514275 [patent_doc_number] => 20090214581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'EPITOPE PEPTIDES DERIVED FROM VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1 AND VACCINES CONTAINING THESE PEPTIDES' [patent_app_type] => utility [patent_app_number] => 11/816893 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10207 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214581.pdf [firstpage_image] =>[orig_patent_app_number] => 11816893 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/816893
Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides Feb 16, 2006 Issued
Array ( [id] => 5618913 [patent_doc_number] => 20060188446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'T-cell epitope peptides' [patent_app_type] => utility [patent_app_number] => 11/354543 [patent_app_country] => US [patent_app_date] => 2006-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5527 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188446.pdf [firstpage_image] =>[orig_patent_app_number] => 11354543 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/354543
T-cell epitope peptides Feb 13, 2006 Issued
Array ( [id] => 5693733 [patent_doc_number] => 20060153880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Pharmaceutical use of alpha antigen or alpha antigen gene' [patent_app_type] => utility [patent_app_number] => 11/352342 [patent_app_country] => US [patent_app_date] => 2006-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5346 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153880.pdf [firstpage_image] =>[orig_patent_app_number] => 11352342 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/352342
Pharmaceutical use of alpha antigen or alpha antigen gene Feb 12, 2006 Issued
Array ( [id] => 5608029 [patent_doc_number] => 20060269545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/348526 [patent_app_country] => US [patent_app_date] => 2006-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 48153 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 39 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269545.pdf [firstpage_image] =>[orig_patent_app_number] => 11348526 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/348526
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof Feb 6, 2006 Issued
Array ( [id] => 5608029 [patent_doc_number] => 20060269545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/348526 [patent_app_country] => US [patent_app_date] => 2006-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 48153 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 39 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269545.pdf [firstpage_image] =>[orig_patent_app_number] => 11348526 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/348526
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof Feb 6, 2006 Issued
Array ( [id] => 5171325 [patent_doc_number] => 20070071756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Delivery of an agent to ameliorate inflammation' [patent_app_type] => utility [patent_app_number] => 11/348017 [patent_app_country] => US [patent_app_date] => 2006-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6180 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20070071756.pdf [firstpage_image] =>[orig_patent_app_number] => 11348017 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/348017
Delivery of an agent to ameliorate inflammation Feb 5, 2006 Abandoned
Array ( [id] => 5172500 [patent_doc_number] => 20070072933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Delivery of an ocular agent' [patent_app_type] => utility [patent_app_number] => 11/348465 [patent_app_country] => US [patent_app_date] => 2006-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7913 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072933.pdf [firstpage_image] =>[orig_patent_app_number] => 11348465 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/348465
Delivery of an ocular agent Feb 5, 2006 Abandoned
Array ( [id] => 5842196 [patent_doc_number] => 20060121025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'VEGF-related protein' [patent_app_type] => utility [patent_app_number] => 11/346806 [patent_app_country] => US [patent_app_date] => 2006-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25887 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121025.pdf [firstpage_image] =>[orig_patent_app_number] => 11346806 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/346806
VEGF-related protein Feb 2, 2006 Abandoned
Array ( [id] => 4681804 [patent_doc_number] => 20080248030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Method of Treating Angiogenic Diseases' [patent_app_type] => utility [patent_app_number] => 11/883501 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 8413 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248030.pdf [firstpage_image] =>[orig_patent_app_number] => 11883501 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/883501
Method of Treating Angiogenic Diseases Feb 1, 2006 Abandoned
Menu